Ivermectin, a broadly-used old drug as an antiparasitic compound, is a drug candidate for repurposing as an anticancer drug (Alout and Foy, 2017). Accumulating evidence suggests that ivermectin has anticancer activities against breast cancer, digestive system cancer, urinary system cancer, hematological cancer, reproductive system cancer, brain glioma, respiratory system cancer, and Melanoma (Tang et al., 2021). https://www.frontiersin.org/articles/10.3389/fphar.2021.717529/full
You must log in to post a comment.